Data in Brief (Jun 2022)

Glioma dataset from Rabat: Clinicopathological, immunohistochemical and disease progression features of 32 Moroccan patients with diffuse Glioma

  • Fatima Sfifou,
  • Mounir Ouzir,
  • El Mehdi Hakkou,
  • Majdouline Obtel,
  • Hassan Errihani,
  • Abderrahmane Al Bouzidi,
  • Redouane Abouqal,
  • Abdessamad El Ouahabi,
  • Nadia Cherradi

Journal volume & issue
Vol. 42
p. 108265

Abstract

Read online

The Moroccan Glioma Dataset contains the clinical data of 32 patients with glioma. The clinical data including demographic data (age, sex), tumor characteristics (tumor location, Glioma type, Karnofsky performance score, mitotic activity, cell density, necrosis, endotheliocapillary vascular proliferation, MRI contrast pick-up, corpus collosum infiltration and Oedema), treatment strategy (subtotal resection, gross resection, biopsy, radiotherapy, chemotherapy), expression pattern of tumor biomarkers (IDH1, HIF-1alpha, P53, Ki-67), and survival data (Kaplan-Meier curves for disease progression). The dataset can be used to relate tumor characteristics to tumor biomarkers and to predict disease progression for a better treatment management. The data were presented, analyzed, and described in the article “Immunohistochemical expression of HIF-1α, IDH1 and TP53: prognostic profile of Moroccan patients with diffuse glioma” published in Journal of Chemical Neuroanatomy [1].

Keywords